CDKN2A and cancer: These investigations have revealed a high load of coding mutations affecting established cancer genes such as TP53, CDKN2A, PTEN, PIK3CA, and HRAS, as well as novel alterations in genes that regulate squamous differentiation (e.g., NOTCH1, IRF6, and TP63) [2].